BioNexus Gene Lab (BGLC) Amortizatization of Intangibles (2019 - 2026)
BioNexus Gene Lab recorded quarterly Amortizatization of Intangibles of $15589.0 in Q1 2026, up 5.56% quarter-over-quarter from $14768.0 in Q4 2025, and up 16.52% year-over-year from $13379.0 in Q1 2025.
BioNexus Gene Lab's Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $15589.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 16.52% year-over-year to $15589.0; the TTM figure through Mar 2026 stood at $58644.0 (up 10.83% YoY), while the FY2025 annual figure was $56434.0, up 15.21% from the prior year.
- Amortizatization of Intangibles came in at $15589.0 for Q1 2026 at BioNexus Gene Lab, up from $14768.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $15589.0 in Q1 2026 to a low of $1238.0 in Q4 2022.
- A 5-year average of $9421.6 and a median of $9550.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles tumbled 66.74% in 2022 and jumped 671.41% in 2023, its largest moves.
- BioNexus Gene Lab's Amortizatization of Intangibles stood at $1238.0 in 2022, then surged by 671.41% to $9550.0 in 2023, then soared by 41.11% to $13476.0 in 2024, then increased by 9.59% to $14768.0 in 2025, then increased by 5.56% to $15589.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $15589.0, $14768.0, and $14354.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | - |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | - |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 88.50 Mn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 77.30 Mn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | - |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | - |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | - |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | - |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | - |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | 15,589.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,589.00 |
| Mar 31, 2026 | 15,589.00 |
| Dec 31, 2025 | 14,768.00 |
| Dec 31, 2025 | 14,768.00 |
| Sep 30, 2025 | 14,354.00 |
| Sep 30, 2025 | 14,354.00 |
| Jun 30, 2025 | 13,933.00 |
| Jun 30, 2025 | 13,933.00 |
| Mar 31, 2025 | 13,379.00 |
| Mar 31, 2025 | 13,379.00 |
| Dec 31, 2024 | 13,476.00 |
| Dec 31, 2024 | 13,476.00 |
| Sep 30, 2024 | 14,807.00 |
| Sep 30, 2024 | 14,807.00 |
| Jun 30, 2024 | 11,252.00 |
| Jun 30, 2024 | 11,252.00 |
| Mar 31, 2024 | 9,448.00 |
| Mar 31, 2024 | 9,448.00 |
| Dec 31, 2023 | 9,550.00 |
| Dec 31, 2023 | 9,550.00 |
| Sep 30, 2023 | 7,729.00 |
| Sep 30, 2023 | 7,729.00 |
| Jun 30, 2023 | 3,919.00 |
| Jun 30, 2023 | 3,919.00 |
| Mar 31, 2023 | 3,972.00 |
| Mar 31, 2023 | 3,972.00 |
| Dec 31, 2022 | 1,238.00 |
| Dec 31, 2022 | 1,238.00 |
| Sep 30, 2022 | 4,168.00 |
| Sep 30, 2022 | 4,168.00 |
| Jun 30, 2022 | 4,245.00 |
| Jun 30, 2022 | 4,245.00 |
| Mar 31, 2022 | 4,341.00 |
| Mar 31, 2022 | 4,341.00 |
| Dec 31, 2021 | 3,722.00 |
| Dec 31, 2021 | 3,722.00 |
| Sep 30, 2021 | 4,350.00 |
| Sep 30, 2021 | 4,350.00 |
| Jun 30, 2021 | 4,427.00 |
| Jun 30, 2021 | 4,427.00 |
| Mar 31, 2021 | 4,434.00 |
| Mar 31, 2021 | 4,434.00 |
| Dec 31, 2020 | 2,606.00 |
| Dec 31, 2020 | 2,606.00 |
| Sep 30, 2020 | -2,606.00 |
| Sep 30, 2020 | -2,606.00 |
| Jun 30, 2020 | 7,951.00 |
| Jun 30, 2020 | 7,951.00 |
| Mar 31, 2020 | 2,865.00 |
| Mar 31, 2020 | 2,865.00 |
| Dec 31, 2019 | 11,618.00 |
| Dec 31, 2019 | 11,618.00 |